REDWOOD CITY, Calif., Aug. 31, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September:
- BioCentury 24th Annual NewsMakers in the Biotech Industry Conference on Friday, September 8, 2017 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time). The conference is being held at the Millennium Broadway Hotel & Conference Center in New York City;
- Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 5:05 p.m. Eastern time (2:05 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City;
- 2017 KeyBanc Capital Market’s Basic Materials & Packaging Conference on Wednesday, September 13, 2017 at the InterContinental Boston; and
- Janney Montgomery Scott’s Bioproduction & Biostorage Forum on Tuesday, September 19, 2017 at the Union League Club in New York City.
A live webcast and replay of the presentations at the NewsMakers and Rodman & Renshaw Conferences will be available on the Investors section of the company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
Contacts: Investors LHA Investor Relations Jody Cain (310) 691-7100 [email protected] Media SCORR Marketing Lea Studer (308) 237-5567 [email protected]


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



